Anti-Human CD141/THBD Polyclonal Antibody (HY397014)

Name: Anti-Human CD141/THBD Polyclonal Antibody
Brand: abinScience
SKU: HY397014
Price: 168 USD
Availability: InStock

Datasheet Compartir producto Copiar información

Precio(USD):

Especificación:

50ug
100ug

Número:

Contáctenos

Vista general
Imágenes
Referencias
Datasheet
SDS

Vista general

Número de catálogo

HY397014

Descripción

Anti-Human CD141/THBD Polyclonal Antibody (HY397014) is a rabbit polyclonal antibody detecting CD141 in ELISA, IHC, WB. Suitable for Human.

Highlights

●Affinity Purified — Minimal background and high purity for reliable results.
●Multi-Application — Validated across multiple applications.

Reactividad de especies

Human

Aplicaciones

ELISA, IHC, WB

Especie huésped

Rabbit

Clonalidad

Polyclonal

Isotipo

IgG

Inmunógeno

E. coli - derived recombinant Human CD141/THBD (Ala19-Asp486).

Objetivo

THBD, THRM, CD141, Thrombomodulin, Fetomodulin, TM

Nivel de endotoxinas

Please contact with the lab for this information.

Pureza

>95% as determined by SDS-PAGE.

Purificación

Purified by antigen affinity column.

Número de acceso

P07204

Forma

Liquid

Buffer de almacenamiento

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Consulte la información específica del buffer en la copia impresa del datasheet o en el COA específico del lote.

Información de uso del producto

Aplicación	Dilución
ELISA	1:5000-1:20000
IHC	1:50-1:500
WB	1:500-1:2000

Estabilidad y almacenamiento

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Fondo

Thrombomodulin (CD141/THBD) is a ~60 kDa protein. Endothelial cell receptor that plays a critical role in regulating several physiological processes including hemostasis, coagulation, fibrinolysis, inflammation, and angiogenesis. Acts as a cofactor for thrombin activation of protein C/PROC on the surface of vascular endothelial cells leading to initiation of the activated protein C anticoagulant pathway. Also accelerates the activation of the plasma carboxypeptidase B2/CPB2, which catalyzes removal of C-terminal basic amino acids from its substrates including kinins or anaphylatoxins leading to fibrinolysis inhibition. Plays critical protective roles in changing the cleavage specificity of protease-activated receptor 1/PAR1, inhibiting endothelial cell permeability and inflammation. Suppresses inflammation distinctly from its anticoagulant cofactor activity by sequestering HMGB1 thereby preventing it from engaging cellular receptors such as RAGE and contributing to the inflammatory response.

1. Fuentes-Prior, P. et al. (2000) Nature 404, 518-25. PMID: 10761923

2. Daly, C. et al. (2018) Scientific reports 8, 505. PMID: 29323190

3. Giri, H. et al. (2021) Proceedings of the National Academy of Sciences of the United States of America 118. PMID: 33836597

4. Dudek, AZ. et al. (1997) The Journal of biological chemistry 272, 31785-92. PMID: 9395524

5. Wu, C. et al. (2016) Journal of thrombosis and haemostasis : JTH 14, 366-74. PMID: 26663133

6. Abeyama, K. et al. (2005) The Journal of clinical investigation 115, 1267-74. PMID: 15841214

Nota

For research use only.

Imágenes

Referencias

Datasheet